MedPath

APO-GLICLAZIDE MR

APO-GLICLAZIDE MR

Approved
DIN Number

02407124

Drug Class

Human

Market Date

Apr 14, 2015

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02407124
AIG Number0119934003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BB09 GLICLAZIDE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification68:20.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

GLICLAZIDEActive
Strength: 60 MG
Monograph: GLICLAZIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.